Product
NVX-CoV2373 + NVX-CoV2540
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Multi-Part, Phase 3, Randomized, Observer Blinded Study to Evaluate the Safety and Immunogenicity of Omicron Subvariant and Bivalent SARS-CoV-2 rS Vaccines in Adults Previously Vaccinated With Other COVID-19 VaccinesStatus: Completed, Estimated PCD: 2022-07-17